Ono Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Ono Pharmaceutical has a total shareholder equity of ¥816.4B and total debt of ¥150.0B, which brings its debt-to-equity ratio to 18.4%. Its total assets and total liabilities are ¥1,083.7B and ¥267.3B respectively. Ono Pharmaceutical's EBIT is ¥149.6B making its interest coverage ratio -29.7. It has cash and short-term investments of ¥150.9B.
Key information
18.4%
Debt to equity ratio
JP¥150.00b
Debt
| Interest coverage ratio | -29.7x |
| Cash | JP¥150.92b |
| Equity | JP¥816.41b |
| Total liabilities | JP¥267.28b |
| Total assets | JP¥1.08t |
Recent financial health updates
Recent updates
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25
Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Financial Position Analysis
Short Term Liabilities: 4528's short term assets (¥387.3B) exceed its short term liabilities (¥252.7B).
Long Term Liabilities: 4528's short term assets (¥387.3B) exceed its long term liabilities (¥14.5B).
Debt to Equity History and Analysis
Debt Level: 4528 has more cash than its total debt.
Reducing Debt: 4528's debt to equity ratio has increased from 0% to 18.4% over the past 5 years.
Debt Coverage: 4528's debt is well covered by operating cash flow (80.7%).
Interest Coverage: 4528 earns more interest than it pays, so coverage of interest payments is not a concern.